SenesTech (NASDAQ:SNES) Now Covered by StockNews.com

Analysts at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright reissued a “buy” rating and set a $35.00 price objective on shares of SenesTech in a research report on Tuesday, May 14th.

SenesTech Stock Down 3.7 %

NASDAQ SNES opened at $3.13 on Thursday. The company has a quick ratio of 3.49, a current ratio of 4.68 and a debt-to-equity ratio of 0.05. The firm’s fifty day moving average price is $4.69 and its 200 day moving average price is $6.68. SenesTech has a 12 month low of $2.65 and a 12 month high of $78.00.

SenesTech (NASDAQ:SNES) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($3.20) by $0.12. SenesTech had a negative net margin of 464.09% and a negative return on equity of 168.64%. The company had revenue of $0.46 million for the quarter, compared to the consensus estimate of $0.49 million. During the same period last year, the firm posted ($84.03) EPS. Sell-side analysts anticipate that SenesTech will post -11 earnings per share for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in SenesTech stock. McAdam LLC bought a new position in SenesTech, Inc. (NASDAQ:SNES) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned 1.25% of SenesTech as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 5.19% of the company’s stock.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.